fenofibrate has been researched along with Primary Ovarian Insufficiency in 1 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Primary Ovarian Insufficiency: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelzaher, WY | 1 |
| Abdel-Hafez, SMN | 1 |
| Rofaeil, RR | 1 |
| Ali, AHSA | 1 |
| Hegazy, A | 1 |
| Bahaa, HA | 1 |
1 other study available for fenofibrate and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
The protective effect of fenofibrate, triptorelin, and their combination against premature ovarian failure in rats.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Combinations; Drug Therapy, Combination; Fema | 2021 |